UniProt ID | GMEB1_HUMAN | |
---|---|---|
UniProt AC | Q9Y692 | |
Protein Name | Glucocorticoid modulatory element-binding protein 1 | |
Gene Name | GMEB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 573 | |
Subcellular Localization | Nucleus. Cytoplasm. May be also cytoplasmic. | |
Protein Description | Trans-acting factor that binds to glucocorticoid modulatory elements (GME) present in the TAT (tyrosine aminotransferase) promoter and increases sensitivity to low concentrations of glucocorticoids. Binds also to the transferrin receptor promoter. Essential auxiliary factor for the replication of parvoviruses.. | |
Protein Sequence | MANAEVSVPVGDVVVVPTEGNEGENPEDTKTQVILQLQPVQQGLFIDGHFYNRIYEAGSENNTAVVAVETHTIHKIEEGIDTGTIEANEDMEIAYPITCGESKAILLWKKFVCPGINVKCVKFNDQLISPKHFVHLAGKSTLKDWKRAIRLGGIMLRKMMDSGQIDFYQHDKVCSNTCRSTKFDLLISSARAPVPGQQTSVVQTPTSADGSITQIAISEESMEEAGLEWNSALTAAVTMATEEGVKKDSEEISEDTLMFWKGIADVGLMEEVVCNIQKEIEELLRGVQQRLIQAPFQVTDAAVLNNVAHTFGLMDTVKKVLDNRRNQVEQGEEQFLYTLTDLERQLEEQKKQGQDHRLKSQTVQNVVLMPVSTPKPPKRPRLQRPASTTVLSPSPPVQQPQFTVISPITITPVGQSFSMGNIPVATLSQGSSPVTVHTLPSGPQLFRYATVVSSAKSSSPDTVTIHPSSSLALLSSTAMQDGSTLGNMTTMVSPVELVAMESGLTSAIQAVESTSEDGQTIIEIDPAPDPEAEDTEGKAVILETELRTEEKVVAEMEEHQHQVHNVEIVVLED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MANAEVSVP ------CCCCEEEEE | 24.76 | 19413330 | |
110 | Ubiquitination | KAILLWKKFVCPGIN HHEEEEHHEECCCCC | 31.29 | - | |
119 | Ubiquitination | VCPGINVKCVKFNDQ ECCCCCEEEEEECCE | 28.90 | - | |
122 | Ubiquitination | GINVKCVKFNDQLIS CCCEEEEEECCEECC | 48.17 | - | |
129 | Phosphorylation | KFNDQLISPKHFVHL EECCEECCHHHEEEC | 36.17 | 25159151 | |
131 | Ubiquitination | NDQLISPKHFVHLAG CCEECCHHHEEECCC | 42.77 | - | |
139 | Ubiquitination | HFVHLAGKSTLKDWK HEEECCCCCCHHHHH | 34.36 | - | |
143 | Ubiquitination | LAGKSTLKDWKRAIR CCCCCCHHHHHHHHH | 62.73 | - | |
146 | Ubiquitination | KSTLKDWKRAIRLGG CCCHHHHHHHHHHCH | 41.93 | - | |
158 | Ubiquitination | LGGIMLRKMMDSGQI HCHHHHHHHHHCCCC | 34.32 | - | |
172 | Ubiquitination | IDFYQHDKVCSNTCR CCEEECCCCCCCCCC | 42.91 | - | |
182 | Ubiquitination | SNTCRSTKFDLLISS CCCCCCCCHHEEEEE | 37.82 | - | |
189 | Phosphorylation | KFDLLISSARAPVPG CHHEEEEECCCCCCC | 18.12 | 28555341 | |
204 | Phosphorylation | QQTSVVQTPTSADGS CCCEEEECCCCCCCC | 19.54 | 26074081 | |
206 | Phosphorylation | TSVVQTPTSADGSIT CEEEECCCCCCCCEE | 39.68 | 26074081 | |
207 | Phosphorylation | SVVQTPTSADGSITQ EEEECCCCCCCCEEE | 26.09 | 26074081 | |
241 | O-linked_Glycosylation | TAAVTMATEEGVKKD HHHHHHHHHHCCCCC | 24.60 | 30059200 | |
249 | O-linked_Glycosylation | EEGVKKDSEEISEDT HHCCCCCHHHCCHHH | 46.11 | 30059200 | |
285 | Methylation | KEIEELLRGVQQRLI HHHHHHHHHHHHHHH | 56.72 | - | |
319 | Ubiquitination | GLMDTVKKVLDNRRN CHHHHHHHHHHCCHH | 43.63 | - | |
350 | Ubiquitination | ERQLEEQKKQGQDHR HHHHHHHHHCCCCCH | 50.79 | - | |
372 | Phosphorylation | NVVLMPVSTPKPPKR EEEEEECCCCCCCCC | 32.87 | 29978859 | |
373 | Phosphorylation | VVLMPVSTPKPPKRP EEEEECCCCCCCCCC | 35.25 | 29978859 | |
406 | Phosphorylation | QPQFTVISPITITPV CCCEEEEECEEEECC | 13.10 | 26074081 | |
409 | Phosphorylation | FTVISPITITPVGQS EEEEECEEEECCCCC | 23.37 | 26074081 | |
411 | Phosphorylation | VISPITITPVGQSFS EEECEEEECCCCCCC | 11.85 | 26074081 | |
428 | O-linked_Glycosylation | NIPVATLSQGSSPVT CCCEEEECCCCCCEE | 28.30 | OGP | |
432 | Phosphorylation | ATLSQGSSPVTVHTL EEECCCCCCEEEEEC | 30.16 | - | |
438 | O-linked_Glycosylation | SSPVTVHTLPSGPQL CCCEEEEECCCCCCE | 35.71 | 30059200 | |
441 | O-linked_Glycosylation | VTVHTLPSGPQLFRY EEEEECCCCCCEEEE | 67.24 | 30059200 | |
450 | O-linked_Glycosylation | PQLFRYATVVSSAKS CCEEEEEEEHHCCCC | 16.71 | 30059200 | |
453 | O-linked_Glycosylation | FRYATVVSSAKSSSP EEEEEEHHCCCCCCC | 21.90 | 30059200 | |
454 | O-linked_Glycosylation | RYATVVSSAKSSSPD EEEEEHHCCCCCCCC | 28.27 | 30059200 | |
457 | Phosphorylation | TVVSSAKSSSPDTVT EEHHCCCCCCCCCEE | 35.45 | 26074081 | |
457 | O-linked_Glycosylation | TVVSSAKSSSPDTVT EEHHCCCCCCCCCEE | 35.45 | 30059200 | |
458 | Phosphorylation | VVSSAKSSSPDTVTI EHHCCCCCCCCCEEE | 45.22 | 26074081 | |
458 | O-linked_Glycosylation | VVSSAKSSSPDTVTI EHHCCCCCCCCCEEE | 45.22 | 30059200 | |
459 | Phosphorylation | VSSAKSSSPDTVTIH HHCCCCCCCCCEEEC | 33.61 | 26074081 | |
459 | O-linked_Glycosylation | VSSAKSSSPDTVTIH HHCCCCCCCCCEEEC | 33.61 | 30059200 | |
462 | Phosphorylation | AKSSSPDTVTIHPSS CCCCCCCCEEECCCC | 23.96 | 26074081 | |
464 | O-linked_Glycosylation | SSSPDTVTIHPSSSL CCCCCCEEECCCCHH | 18.70 | 30059200 | |
464 | Phosphorylation | SSSPDTVTIHPSSSL CCCCCCEEECCCCHH | 18.70 | 26074081 | |
468 | O-linked_Glycosylation | DTVTIHPSSSLALLS CCEEECCCCHHHHHH | 20.56 | 30059200 | |
470 | O-linked_Glycosylation | VTIHPSSSLALLSST EEECCCCHHHHHHCC | 23.23 | 30059200 | |
538 | Sumoylation | EAEDTEGKAVILETE CCCCCCCCEEEEEEE | 32.99 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GMEB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GMEB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TRI63_HUMAN | TRIM63 | physical | 11927605 | |
UBC9_RAT | Ube2i | physical | 11812797 | |
GMEB2_HUMAN | GMEB2 | physical | 28514442 | |
MATN4_HUMAN | MATN4 | physical | 28514442 | |
DHRS2_HUMAN | DHRS2 | physical | 28514442 | |
WDR54_HUMAN | WDR54 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-129, AND MASSSPECTROMETRY. |